CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $800,380 | +7.9% | 50,400 | -44.8% | 0.13% | -1.5% |
Q2 2023 | $741,763 | +24725333.3% | 91,300 | +352.0% | 0.13% | – |
Q4 2022 | $3 | -100.0% | 20,200 | -38.0% | 0.00% | -100.0% |
Q3 2022 | $286,000 | -34.4% | 32,600 | -13.3% | 0.02% | -9.5% |
Q2 2022 | $436,000 | -70.4% | 37,600 | -30.3% | 0.02% | -66.1% |
Q1 2022 | $1,475,000 | -31.3% | 53,951 | -25.9% | 0.06% | +6.9% |
Q4 2021 | $2,147,000 | +235.5% | 72,781 | +54.2% | 0.06% | +176.2% |
Q3 2021 | $640,000 | -29.3% | 47,200 | -15.6% | 0.02% | -25.0% |
Q2 2021 | $905,000 | -65.1% | 55,900 | -56.4% | 0.03% | -79.7% |
Q1 2021 | $2,592,000 | -23.5% | 128,083 | +95.1% | 0.14% | +40.8% |
Q4 2020 | $3,388,000 | +697.2% | 65,654 | +297.9% | 0.10% | +366.7% |
Q3 2020 | $425,000 | -65.9% | 16,500 | -63.7% | 0.02% | -69.1% |
Q2 2020 | $1,245,000 | +390.2% | 45,461 | +43.0% | 0.07% | +300.0% |
Q1 2020 | $254,000 | -39.2% | 31,800 | -33.2% | 0.02% | -26.1% |
Q4 2019 | $418,000 | +105.9% | 47,600 | +60.8% | 0.02% | +35.3% |
Q3 2019 | $203,000 | +62.4% | 29,600 | +16.5% | 0.02% | +70.0% |
Q2 2019 | $125,000 | +12.6% | 25,400 | -39.8% | 0.01% | 0.0% |
Q1 2019 | $111,000 | +484.2% | 42,200 | +168.8% | 0.01% | +900.0% |
Q4 2018 | $19,000 | -81.9% | 15,700 | +12.1% | 0.00% | -85.7% |
Q3 2018 | $105,000 | +191.7% | 14,000 | +9.4% | 0.01% | +250.0% |
Q2 2018 | $36,000 | – | 12,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |